Qv Bioelectronics
Qv Bioelectronics is a UK startup, founded in 2018. It has won about £2.20m in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Qv Bioelectronics has won about £2.20m in competitive Innovate UK grants since 2023.
- Pre-clinical validation and first-in-human translation of a novel brain implant to treat glioblastoma (GRACE) (£1.26m, 2025)
- Feasibility of novel therapeutic device for ultra orphan childhood brain tumour (£341k, 2024)
- Development of technology and capabilities critical for clinical translation of first of its kind brain tumour therapy (£603k, 2023)
Related
Questions and answers
What does Qv Bioelectronics do?
Qv Bioelectronics works in electronics and photonics. Its Innovate UK projects include: Pre-clinical validation and first-in-human translation of a novel brain implant to treat glioblastoma (GRACE).
Where is Qv Bioelectronics based?
Qv Bioelectronics is registered in United Kingdom; its operating headquarters is not yet confirmed.
When was Qv Bioelectronics founded?
Qv Bioelectronics was founded in 2018.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.